Lymphoplasmacytic Lymphoma Recruiting Phase 2 Trials for Allopurinol (DB00437)

IndicationStatusPhase
DBCOND0031072 (Lymphoplasmacytic Lymphoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02661035Allo HSCT Using RIC for Hematological DiseasesTreatment